Vahh Chemicals Limited

Basic Materials — Chemicals · BSE

₹45.00−₹1.01 (−2.20%)

DalalBaazaar Score

72 / 100

🟢 Good

Verdict

REASONABLE

Risk

High

Driven by negative free cash flow, micro-cap size, which brings thin liquidity.

In simple words: Strong business and financial position, with both sales and profits growing well. Cash generation is currently the main factor to watch.

Decision support, not a buy or sell call.

As of 18 Oct 2026, 6:08 pm

Mixed / neutral. No major red flags jump out, but nothing here screams "obviously cheap" either. This is a name that needs a peer comparison and a view on near-term earnings triggers before sizing a position.

Understanding the Business

Company site ↗

The 60-second version of Vahh Chemicals Limited — what it does, how it earns, and who it competes with, before any of the numbers below.

What does this company do?

Vahh Chemicals Limited manufactures and trades textile auxiliary chemicals.

IndustryChemicals

SectorBasic Materials

Employees30

Annual revenue₹43 Cr

How does it make money?

Turns over ₹43 Cr a year. Of every ₹100 of sales, about ₹11 reaches shareholders as profit, with ₹19 left at the operating level before interest, tax and depreciation. Each of its 30 employees supports ₹1.44 Cr of revenue a year, the signature of a capital- or asset-led business.

EBITDA margin19.1%

Net margin11.1%

Revenue / employee₹1.44 Cr

Who are its competitors?

The closest listed comparisons in its industry are PIDILITE INDUSTRIES LTD, SRF LTD, UPL LIMITED. These are the companies its valuation and returns are measured against elsewhere in this report.

PIDILITE INDUSTRIES LTDP/E 57.8x · ROE 24.4%

SRF LTDP/E 33.8x · ROE 15.4%

UPL LIMITEDP/E 21.5x · ROE 6.1%

What is its competitive advantage?The numbers suggest a real one

ROCE has stayed above 15% in every year available and stands at 46.6%. Returns that high normally get competed away; when they persist, something is protecting them, and its ROE of 44.6% against a peer median of 15.4% is consistent with that. What that something is — brand, scale, switching costs, regulation — the accounts cannot tell you.

ROCE46.6%

ROE44.6%

Peer median ROE15.4%

What has been driving growth?

Sales and margins have both contributed to where profit is now. Over 3 years revenue moved +479% while net margin moved +390% relative to itself. What this cannot tell you is which products, customers or geographies did the work — that lives in the segment disclosures of the annual report.

Revenue effect+479%

Margin effect+390%

DalalBaazaar Score

72/ 100

Good

Weighted across six categories. Every point is explained below.

✗ Micro Cap: thinner liquidity and sharper drawdowns are normal
✗ Profits have swung sharply from year to year — earnings are hard to forecast
✗ Negative free cash flow means dependence on external funding

Quality vs. Valuation

Company Quality

79/ 100

Good

How good the business is, ignoring the share price entirely.

Valuation

85/ 100

Cheap

What you are being asked to pay, ignoring how good the business is.

A good business currently available at an undemanding price — the combination this framework is built to look for.

Historical Valuation

Current P/E

7.8x

Sector Median

33.8x

median of 3 sector peers

🟢Against its sector it trades 77% below the peer median of 33.8x.

vs. its own history

Not enough price and earnings history

vs. sector peers

Cheap

33.8x median of 3 peers · -77%

vs. generic bands

Cheap

Below 15x

P/E (Trailing)

7.8x

P/B

1.83x

EV/EBITDA

5.8x

PEG

0.04

Dividend Yield

None

What's Good / What's Bad

🟢 What's Going Well5

Margins are improving
EBITDA margin is up from 5.7% to 19.1% over 3 years.
Return on equity is rising
ROE has improved from 24.8% to 32.2%.
Return on capital is rising
ROCE has improved from 21.6% to 46.6%.
High return on capital employed
ROCE of 46.6% is the mark of a business that converts capital into profit efficiently.
Consistently profitable
Profitable in every one of the last 4 reported years.

🔴 What Needs Attention3

Debt is rising
Total debt is up 309% over 3 years — worth checking what it funded.
Free cash flow is negative
The business is not currently covering its capital spending from operations.
Inventory building faster than sales
Inventory is up 3199% against revenue growth of 479% — stock may not be moving.

Red Flags

3 items require attention · 3 high

🔴Debt has risen sharplyFinancial
Total debt is up 309% over 3 years, from ₹3 Cr to ₹11 Cr.
🔴Free cash flow negative for 4 yearsFinancial
The business has not covered its capital spending from operations for several years running, which has to be funded externally.
🔴Inventory building faster than salesFinancial
Inventory up 3199% against revenue up 479% — stock may not be moving.

Investment Thesis

🟢 Bull CaseWhat could make this work?

Capital compounds at a high rate
ROCE of 46.6% means each rupee reinvested earns well above what capital costs. If the company can keep deploying at this rate, growth creates value rather than just consuming cash.
Margin expansion has further to run
EBITDA margin has risen from 5.7% to 19.1%. If that holds, profit compounds faster than sales and today's multiple looks cheaper in hindsight than it does now.
Cheaper than its peers
It trades 77% below the sector median. Either the market sees a problem the numbers do not show, or the discount closes.
Earnings have proved durable
Profitable in every one of the last 4 reported years. Consistency lowers the risk that any single bad year is structural rather than cyclical.

🔴 Bear CaseWhat could go wrong?

Earnings are hard to forecast
Profit has swung sharply from year to year, so any single year — good or bad — is a weak guide to the next. Cyclical earnings deserve lower multiples for that reason.
Size brings its own risk
Micro Cap businesses are thinly traded, so exits are harder in a falling market and single events move the price more than they would for a larger company.
Several serious flags at once
3 high-severity checks triggered. Individually each has an explanation; together they raise the chance that something structural is wrong rather than a one-off.

🟡 Key Things to WatchMeasurable tripwires, set against where this company stands today

1Revenue growth stays above 60% a year✓ 79.5% CAGR
Latest reported year was 81.7%. The bar is set below the established compounding rate, so ordinary variation does not trip it.
2EBITDA margin holds above 17%✓ 19.1%
Two points below today's level — enough room for noise, tight enough to catch real compression.
3Free cash flow remains positive✗ -₹4 Cr
Profit that never becomes cash eventually stops being profit.
4Debt / EBITDA stays below 2x✓ 1.4x
The ratio lenders write covenants against; it survives a small or negative equity base, unlike Debt/Equity.
5ROCE stays above 44%✓ 46.6%
Falling returns on capital are usually competition arriving, and show up here before they reach the margin.

Investment Checklist

9 / 11 checks passed

✓ Strong return on equity (ROE ≥ 15%)
✓ Strong return on capital employed (ROCE ≥ 15%)
✓ Healthy net margin (≥ 10%)
✗ Generates positive free cash flow
✓ Manageable leverage (Debt/Equity < 1.0)
✓ Adequate short-term liquidity (Current Ratio ≥ 1.0)
✓ Revenue growing year-over-year
✓ Profit growing year-over-year
✓ Not trading at an extreme valuation (P/E < 40x)
✓ Not buying right at the 52-week high
✗ Short-term technical trend isn't bearish

Price history

Quick Metrics

6 good · 4 neutral · 1 weak

Market Cap

₹37 Cr

Micro Cap

Smaller company — thin liquidity and deep drawdowns are normal here

P/E (Trailing)

7.8x

Cheap

Cheap against the generic band

P/B Ratio

1.83x

Fair

Moderate premium to the company's book value

EPS (TTM)

₹5.79

Profitable

Profitable on a per-share basis

ROE

44.6%

Strong

Strong capital efficiency

ROCE

46.6%

Strong

Earns comfortably above its likely cost of capital

Debt/Equity

0.73x

Moderate

Moderate leverage

Revenue Growth (YoY)

81.7%

Healthy

Healthy top-line growth

Profit Growth (YoY)

81.6%

Healthy

Profits growing at a healthy clip

Dividend Yield

None

No dividend yield reported — usually means no payout, but verify if one was recently initiated

Free Cash Flow

-₹6 Cr

Cash burning

Spending more cash than the operations bring in

More Metrics

CMP

₹45

ROA

12.5%

Good

Assets are working hard

Operating Margin

18.3%

Good

Healthy core-business profitability

Net Margin

11.1%

Good

Strong bottom-line conversion

Current Ratio

1.66

Comfortable

Healthy short-term liquidity

52W Range Position

Near low

Near its 52-week low

Technical Snapshot

SMA 20 / SMA 50

49.5 / 51.1

Bearish alignment (short < long)

RSI (14)

0.0

Oversold zone

Financial Trend (4-Year)

Metric	FY23	FY24	FY25	FY26	3Y CAGR
Revenue	₹7 Cr	₹10 Cr	₹24 Cr	₹43 Cr	+79.5%
EBITDA	₹0 Cr	₹1 Cr	₹5 Cr	₹8 Cr	+168.6%
EBITDA Margin	5.7%	11.1%	19.7%	19.1%	—
PAT (Net Profit)	₹0 Cr	₹0 Cr	₹3 Cr	₹5 Cr	+205.0%
EPS	₹0.2	₹0.41	₹3.19	—	—
ROE	24.8%	33.6%	38.5%	32.2%	—
ROCE	21.6%	26.2%	49.2%	46.6%	—
Total Debt	₹3 Cr	₹6 Cr	₹11 Cr	₹11 Cr	+59.9%
Free Cash Flow	-₹0 Cr	-₹2 Cr	-₹6 Cr	-₹4 Cr	—

🟢 Revenue has grown at 79.5% a year over 3 years.

🟢 EBITDA has grown at 168.6% a year over 3 years.

🟢 EBITDA Margin has risen from 5.7% to 19.1% over 3 years (+13.4 pts).

🟢 PAT (Net Profit) has grown at 205.0% a year over 3 years.

🟢 ROE has risen from 24.8% to 32.2% over 3 years (+7.4 pts).

🟢 ROCE has risen from 21.6% to 46.6% over 3 years (+25.0 pts).

🔴 Total Debt has grown at 59.9% a year over 3 years.

Balance Sheet & Cash Flow — FY2026

Total Assets

₹44 Cr

Total Liabilities

₹28 Cr

Total Debt

₹11 Cr

Cash & Equivalents

₹1 Cr

Operating Cash Flow

-₹4 Cr

Capex

-₹0 Cr

Shareholding (proxy)

Institutional Holding

0.0%

Insider Holding

72.5%

Peer Comparison

Company	P/E	ROE
PIDILITE INDUSTRIES LTD	57.8x	24.4%
SRF LTD	33.8x	15.4%
UPL LIMITED	21.5x	6.1%

Recent News

6 general

Compare with

Equitymaster, 14 Oct

Vahh Chemicals Ltd. IPO Review - Vahh Chemicals Ltd. IPO Dates, Issue Price, Subscription and Allotment Status

The Economic Times, 27 Sept

Vahh Chemicals shares list at 17% premium over IPO price on BSE SME platform

The Economic Times, 11 Jun

Vahh Chemicals Limited Share Price

Upstox, 11 Jun

Vahh Chemicals share price lists at 17% premium over IPO price on BSE SME

Livemint, 11 Jun

VAHH Chemicals Limited’s Initial Public Offering Opens on June 4 to June 8, 2026 with Price Fixed at Rs.60 Per Share

ThePrint, 03 Jun

Watch Items

Trading very close to its 52-week low — worth checking whether this reflects a temporary setback or a structural problem.
Cross-check against the company's latest quarterly filing / investor presentation before acting.
RSI is in oversold territory — could mean either a bargain or a stock still falling for good reason. Check the 'why' before assuming reversal.

DalalBaazaar Thesis

🟢Business QualityStrong15.4/20

🟡Financial HealthAdequate12/20

🟢GrowthStrong18.5/20

🟢ProfitabilityStrong12.9/15

🟢ValuationAttractive11/15

🔴RiskHigh2.5/10

Attractive on both counts

A good business currently available at an undemanding price — the combination this framework exists to look for. The work left is qualitative: whether the advantage the numbers imply is one you can identify and expect to last. 3 high-severity red flags sit above this conclusion and should be read first.

This thesis breaks if

✓Revenue growth stays above 60% a year79.5% CAGR
✓EBITDA margin holds above 17%19.1%
✗Free cash flow remains positive-₹4 Cr
✓Debt / EBITDA stays below 2x1.4x
✓ROCE stays above 44%46.6%